Skip to content

Inflammatory Effects of a Lung Recruitment Manoeuvre

Prospective, Open, Uncontrolled, Non-randomized and Monocentric Trial on the Efficacy and the Inflammatory Effects of a Lung Recruitment Manoeuvre in Mechanical Ventilated Patients With Respiratory Failure

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01070654
Enrollment
10
Registered
2010-02-18
Start date
2010-06-30
Completion date
2010-12-31
Last updated
2010-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory Distress Syndrome, Adult, Respiratory Insufficiency

Keywords

ARDS, Recruitment Manoeuvres, PEEP, Cytokines, Respiratory Insufficiency

Brief summary

Recruitment manoeuvres, consisting of sustained inflations at high airway pressures, have been advocated as an adjunct to mechanical ventilation in lung protective ventilation strategies to prevent the collapse of the lung. This study aims to determine the safety and efficacy of a recruitment manoeuvre, by considering its impact on gas exchange, hemodynamics and on the release of systemic inflammatory mediators.

Detailed description

This prospective study will analyse the effects of a single recruitment manoeuvre in critically ill patients. Subjects will be mechanically ventilated patients needing alveolar RMs. After a period of stable lung protective approach ventilation, they will receive the 40/30 RM; lung mechanics, gas exchange, hemodynamics and plasmatic concentration of inflammatory mediators will be obtained before and after the RM. An ultrasound score, established from the lung aeration status of upper and lower parts of anterior and lateral chest wall, will also be calculated before and after the manoeuvre.In selected patients cytokine release in the bronchoalveolar lavage will be measured as well.

Interventions

PROCEDURE40/30 recruitment manoeuvre

The ventilator will be switched to the continuous positive airway pressure (CPAP) mode and the pressure will be increased to 40 cmH20 for 30 seconds.

DEVICEcontinuous positive airway pressure (CPAP)

continuous positive airway pressure (CPAP)

Sponsors

Azienda Ospedaliero, Universitaria Pisana
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Mechanical Ventilation * Arterial catheter inserted * Hypoxemic respiratory failure (Pa02/FiO2 \<300) * Radiological evidence of atelectasis or pulmonary infiltrates in the CXR * Informed consent

Exclusion criteria

* Elevated intracranial pressure \>25 mmHg * Bronchopulmonary fistula * Emphysema * Kidney or Liver failure

Design outcomes

Primary

MeasureTime frame
Plasmatic concentration of inflammatory mediators IL-1, IL-6, IL-8, IL-10, TNFaT0 (baseline), T4 (3 hrs), T5 (12 hrs)
Plasmatic concentration of Nitric OxideT0 (baseline), T6 (24 hrs)
Lung mechanics (Peak pressure, Mean pressure, Compliance, Resistance) Gas exchange (pH, PaO2, PaCO2, HCO3-, SaO2, PaO2/FiO2) Haemodynamics (Mean arterial pressure, Heart rate)T0 (baseline), T1 (30 secs), T2 (1 hr), T3 (2 hrs)
Echographic score of lung aerationT0 (baseline), T2 (1 hr), T4 (3 hrs)
Chest X-RayT6 (24 hrs)

Secondary

MeasureTime frame
Levels of IL-1, IL6, IL-8, IL-19, TNFa in the bronchoalveolar lavageT0 (baseline), T4 (3 hrs)

Countries

Italy

Contacts

Primary ContactFrancesco Forfori
forforiden@libero.it+39050993234
Backup ContactGiuseppe Mancino
giumancino@gmail.com+393471216535

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026